Founded in 1897, the Lonza Group is a leading global manufacturer and supplier of pharmaceutical and biotech products. It develops active pharmaceutical ingredients and innovative dosage forms for the consumer health, pharma and nutrition industries. The company offers a range of personal healthcare ingredients, including drinking water sanitizers, antidandruff agents and nutraceuticals. Additionally, it produces agricultural products, such as advanced coatings and microbial control solutions that fight against dangerous viruses and bacteria. With more than 50 key research and development centres and production facilities, Lonza employs 14,000 people. Headquartered in Basel, Switzerland, the Lonza Group share price (LONN) is set and traded on the SIX exchange.
最新股票文章
日圓走勢預測：第三方價格目標
2025年截至目前，美元兌日圓（USD/JPY）匯率年內下跌約9.41%。2025年4月25日，日圓兌美元收於142.8790，創下自2024年9月以來的最強水平之一，較2024年7月的高點161.942下跌約11.77%。
11:17, 19 6月 2025
黃金價格走勢分析2025：第三方目標與市場預測
黃金一直被視為經濟不確定時期的重要避險資產。隨著2025年受中央銀行政策轉向、通脹壓力變化以及地緣政治緊張局勢的影響，黃金在交易圈中仍然備受關注。
21:45, 28 4月 2025
評級和評論
評級和評論
